David Mazzo
@davidmazzo
Executive Officer, Director
Building Caladrius Biosciences, Inc. as Executive Officer, Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
Named alongside
At Caladrius Biosciences, Inc.
- Andrew L. PecoraDirector
- Anne J. WhitakerDirector
- Cynthia S. SchwalmDirector
- David J. MazzoExecutive Officer, Director
- Douglas J. LosordoExecutive Officer
- Douglas L. LosordoExecutive Officer
- Eric S. WeiDirector
- Gregory B. BrownDirector
At EyePoint Pharmaceuticals, Inc.
- Dario Paggiarino, M.D.Senior Vice President and Chief Medical Officer
- Dario S. PaggiarinoVice President, Chief Medical Officer
- David R. Guyer, M.D.Director
- Douglas GodshallDirector
- Douglas W. GodshallDirector
- George O. ElstonChief Financial Officer and Head of Corporate Development
- Goran AndoDirector
- James BarryDirector
- Binxian C WeiDirector
- Binxian WeiDirector
- Catherine SohnDirector
- Cristina C CsimmaDirector
- Cristina CsimmaDirector
- Donald C WilliamsDirector
- Donald WilliamsDirector
- Herbert SladeExecutive Officer
Contribution
David's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Caladrius Biosciences, Inc.Pharmaceutical Preparations; formerly Caladrius Biosciences, Inc.; listed on Nasdaq as LSTA; filing with the SEC since 2011Executive Officer, Director · Biotechnology · BASKING RIDGE, United States
- EyePoint Pharmaceuticals, Inc.Laboratory Analytical Instruments; formerly EyePoint Pharmaceuticals, Inc.; listed on Nasdaq as EYPT; filing with the SEC since 2009Director · Pharmaceuticals · WATERTOWN, United States
- Neuralstem, Inc.Biological Products, (No Diagnostic Substances); listed on Nasdaq as PALI; filing with the SEC since 2011Director · Biotechnology · GERMANTOWN, United States